Geneos Wealth Management Inc.

Position in INSM — INSMED Inc

CIK 1764754 ENGLEWOOD, CO

Position in INSM

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$67,697

-$4,355 QoQ

Shares Held

414

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

13 quarters on record

Healthcare · as of Mar 31, 2026

Geneos Wealth Management Inc. holds $2,712,041 across 32 Biotechnology names. INSM ranks #6 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	12,399	$801,347
2	GALT	Galectin Therapeutics Inc	240,927	$672,186
3	REGN	Regeneron Pharmaceuticals, Inc.	835	$645,154
4	AVXL	Anavex Life Sciences Corp.	48,600	$149,202
5	TGTX	Tg Therapeutics, Inc.	2,169	$72,054
6	INSM	INSMED Inc This page	414	$67,697
7	VRTX	Vertex Pharmaceuticals Inc / Ma	101	$45,100
8	IBRX	ImmunityBio, Inc.	5,754	$44,133

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$67,697	414	0.0%	Shares	Sole	2026-05-05
2025-12-31	$72,052	414	+467.1%	Shares	Sole	2026-01-28
2025-09-30	$10,512	73	-34.2%	Shares	Sole	2025-10-22
2025-06-30	$11,171	111	+105.6%	Shares	Sole	2025-08-18
2025-03-31	$4,119	54	0.0%	Shares	Sole	2025-05-21
2024-12-31	$3,728	54	-80.1%	Shares	Sole	2025-01-21
2021-12-31	$7,409	272	0.0%	Shares	Sole	2022-02-09
2021-09-30	$7,490	272	0.0%	Shares	Sole	2021-11-09
2021-06-30	$7,741	272	0.0%	Shares	Sole	2021-07-08
2021-03-31	$9,264	272	0.0%	Shares	Sole	2021-06-17
2020-12-31	$9,054	272	0.0%	Shares	Sole	2021-05-19
2020-09-30	$8,742	272	0.0%	Shares	Sole	2021-09-07
2020-06-30	$7,490	272	—	Shares	Sole	2021-09-07
No filing history on record for this holder in this stock.